Astel­las pulls law­suit over price ne­go­ti­a­tions as Xtan­di side­steps first list of 10 drugs

Astel­las on Wednes­day vol­un­tar­i­ly dis­missed its law­suit against the Biden ad­min­is­tra­tion’s HHS af­ter its prostate can­cer drug Xtan­di (en­za­lu­tamide) was not in­clud­ed in the ini­tial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER